Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study
Sign Up to like & getrecommendations! Published in 2020 at "BMC Endocrine Disorders"
DOI: 10.1186/s12902-020-0507-8
Abstract: Background Whether lower dose cabergoline therapy for hyperprolactinemia increases risk of valvular dysfunction remains controversial. We examined valvular abnormalities among asymptomatic adults with hyperprolactinemia treated with dopamine agonists. Methods This cross-sectional study was conducted among… read more here.
Keywords: hyperprolactinemia; exposure; cabergoline; compared bromocriptine ... See more keywords